Incyte Corp.
INCY · NASDAQ-GS
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B | $2.67B | $2.16B | $1.88B |
| Cost of Revenue | $372.13M | $312.07M | $254.99M | $207.00M | $150.99M | $131.33M | $114.25M | $94.12M |
| Research & Development | $2.05B | $2.61B | $1.63B | $1.59B | $1.46B | $2.22B | $1.15B | $1.20B |
| Selling, General & Administrative | $1.38B | $1.24B | $1.16B | $1.00B | $739.56M | $516.92M | $468.71M | $434.41M |
| Operating Expenses | $3.63B | $4.18B | $3.08B | $2.82B | $2.40B | $2.93B | $1.76B | $1.75B |
| Operating Income | $1.51B | $61.37M | $620.52M | $579.44M | $585.78M | -$263.68M | $402.01M | $129.22M |
| Interest Expense | — | — | $2.55M | $2.67M | $1.91M | $2.17M | $1.85M | $1.54M |
| Other Income / (Expense) | $25.11M | $12.81M | $13.93M | -$519.00K | $10.65M | $23.21M | $52.18M | $31.76M |
| Income Before Taxes | $1.66B | $316.63M | $834.22M | $529.12M | $570.44M | -$232.22M | $486.79M | $115.35M |
| Provision for Income Taxes | $377.80M | $284.01M | $236.62M | $188.46M | -$378.14M | $63.48M | $39.88M | $5.85M |
| Net Income | $1.29B | $32.60M | $597.60M | $340.70M | $948.60M | -$295.70M | $446.91M | $109.49M |
| Basic EPS | $6.59 | $0.16 | $2.67 | $1.53 | $4.30 | -$1.36 | $2.08 | $0.52 |
| Diluted EPS | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 | -$1.36 | $2.05 | $0.51 |
| Basic Shares Outstanding | 195.20M | 207.11M | 223.63M | 222.00M | 220.43M | 218.07M | 214.91M | 212.38M |
| Diluted Shares Outstanding | 200.70M | 210.53M | 225.93M | 223.96M | 222.07M | 218.07M | 217.66M | 215.63M |
Analyst Estimates
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $1.97 | $0.45 | $3.09 | 10 | ↑0 ↓2 |
| Dec 2027 | $7.55 | $5.43 | $8.65 | 11 | ↑1 ↓6 |
| Dec 2028 | $8.41 | $7.65 | $9.30 | 4 | ↑0 ↓0 |
| Dec 2029 | $1.20 | $1.20 | $1.20 | 1 | ↑0 ↓0 |
